CU Healthcare Innovation Fund

The CU Healthcare Innovation Fund is a $50 million venture capital fund affiliated with the University of Colorado Anschutz Medical Campus. It focuses on investing in early-stage healthcare companies that have a business relationship with the partner institutions, including the University of Colorado, UCHealth, Children's Hospital Colorado, and CU Medicine. The fund primarily targets digital health and healthcare IT ventures that have a co-development relationship with the campus, as well as therapeutics and medical devices developed on the campus and licensed to outside entrepreneurial teams with substantial backing. The fund has already invested in eight companies and continues to pursue new opportunities aggressively.

The fund's close affiliation with the CU Anschutz Medical Campus provides unique access to a pipeline of opportunities that can address clinical and operational challenges faced by health system partners while creating value for the startups it partners with. This collaboration allows the fund to de-risk early-stage investments in new technologies that enable clinicians to improve patient care and better utilize healthcare data to improve decision-making at the point of care or identify new treatments. The goal is to build a portfolio of companies that have an initial product that can leverage the resources of the campus to evolve that product to better meet the needs of healthcare systems and providers nationally, while improving the patient experience and lowering the cost of care.

The CU Healthcare Innovation Fund is managed by a nationally recognized team of healthcare entrepreneurs, investors, and innovation thought leaders with over 200 years of experience in biotechnology and digital health, representing over $30 billion in value creation. The fund has evaluated over 700 companies nationally and has strategic relationships with more than ten multinational healthcare corporations. As of 2023, the fund has over $100 million in assets under management and has invested in a strong pipeline of de-risked companies ready to scale. The fund invests in the top 1% of pipeline companies and has strategic relationships with over ten multinational healthcare corporations.

For more information, please contact Gali Baler at gbaler@cuvcfund.com.